Search results

Selected filters:

Litigation
News

Article type

Topic

Sector

Regions

Year

404 results found for your search

Sort options
24 August 2019

Adversaries no more - licensors look to make deals, not settlements

In its day, the IPNav model was hugely successful in generating cash, but successful licensing in the here and now requires a different, less confrontational approach

14 August 2019

USPTO Director Iancu set to keynote IAM’s patent litigation event as 101 legislation debate continues

American Express, Nokia, Google, Nasdaq, Volkswagen, Novartis and Merck executives among the final speakers revealed for prestigious November conference in Washington DC

10 August 2019

A No Deal Brexit now looks unavoidable, so plan accordingly

Boris Johnson becoming Prime Minister has totally changed the trajectory of the UK's departure from the EU and IP owners' strategies should reflect that

03 August 2019

Life sciences IP – the major developments in July

All the big pharma and biotech patent stories from last month in our regular monthly round-up

25 July 2019

Big CAFC decision gives operating companies that transfer patents to NPEs plenty to consider

The Lone Star ruling squarely puts entities that try to monetise their IP by transferring it to third-parties at risk of being joined in any subsequent litigation

23 July 2019

It's security, stupid - why it's time to see the wood from the trees in the FTC's case against Qualcomm

If the US chipmaker’s recent court defeat stands then the US risks ceding to China a central role in the development of 5G and future wireless technology

18 July 2019

Federal Circuit decision shows door not shut on infringement claims under the doctrine of equivalents in ANDA cases

Ruling in UCB v Watson Laboratories provides important strategic guidance on the doctrine for both patent prosecutors and litigators

10 July 2019

All the big life sciences IP developments in June

Our round-up of the major patent issues affecting pharma and biotech that emerged on the legal, market and policy fronts last month

09 July 2019

Incorrectly naming an RPI will not derail an IPR, Federal Circuit rules

In Mayne Pharma, the court upheld a PTAB final written decision invalidating a patent despite the owner’s objection that all real-parties-in-interest were not properly named in the original review petition

04 July 2019

Why it's time for a new approach to 5G patent licensing

How a more proactive, collaborative approach by SEP licensors - one that focuses on reaching out to start-ups and SMEs - could lead to a lot more deals and a lot less pain

23 June 2019

Rubio’s Huawei proposal should worry US tech, pharma companies

Letting the executive branch neutralise patents whose owners it doesn’t like would weaken the US patent system and invite retaliation by China

21 June 2019

SK Innovation fights US trade secrets suit with Korean defamation case

Battery maker will argue that LG Chem’s US trade secret litigation is against the national interest

19 June 2019

What to do with conflicting testimony on patent eligibility

Former CAFC Chief Judge Michel: “If the public debate is confused by unreliable statements of ill-informed or overzealous advocates, the US will decline and its future will fade.”

17 June 2019

IPBC Global 2019 – Day One highlights

All the big stories from the first full day of the world’s pre-eminent conference about IP value creation